coagulation factor VIIa (recombinant)-jncw (Sevenfact)
coagulation factor VIIa (recombinant)-jncw is an FDA-licensed reference biologic from Laboratoire Francais du Fractionnement et des Biotechnologies S.A.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2024
Reference approved
Reference product
Sevenfact coagulation factor VIIa (recombinant)-jncw
Laboratoire Francais du Fractionnement et des Biotechnologies S.A.
- Approved
- Jun 20, 2024
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for coagulation factor VIIa (recombinant)-jncw, in chronological order.
Reference approval
Approval date of the reference coagulation factor VIIa (recombinant)-jncw product.
2 yr ago
Frequently asked questions
Are there biosimilars approved for coagulation factor VIIa (recombinant)-jncw (Sevenfact)?
No 351(k) biosimilars or interchangeable biosimilars referencing coagulation factor VIIa (recombinant)-jncw are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.